Human papillomaviruses (HPVs) are involved in the pathogenesis of cancer of the cervix (CaCx). MicroRNA (miRNA) expression analysis using Ambion (Austin, TX, USA) arrays showed that three miRNAs were overexpressed and 24 underexpressed in cervical cell lines containing integrated HPV-16 DNA compared to the normal cervix. Furthermore, nine miRNAs were overexpressed and one underexpressed in integrated HPV-16 cell lines compared to the HPV-negative CaCx cell line C-33A. Based on microarray and/or quantitative realtime PCR and northern blot analyses, microRNA-218 (miR-218) was specifically underexpressed in HPVpositive cell lines, cervical lesions and cancer tissues containing HPV-16 DNA compared to both C-33A and the normal cervix. Expression of the E6 oncogene of highrisk HPV-16, but not that of low-risk HPV-6, reduced miR-218 expression, and conversely, RNA interference of E6/E7 oncogenes in an HPV-16-positive cell line increased miR-218 expression. We also demonstrate that the epithelial cell-specific marker LAMB3 is a target of miR-218. We also show that LAMB3 expression is increased in the presence of the HPV-16 E6 oncogene and this effect is mediated through miR-218. These findings may contribute to a better understanding of the molecular mechanisms involved in cervical carcinogenesis.
Introduction
High-risk human papillomaviruses (HPVs) such as types 16 and 18 are causally involved in cervical cancer (zur Hausen, 2002) . HPVs are small double-stranded DNA viruses that contain two oncogenes E6 and E7 that are involved in cellular transformation. Most low-grade cervical lesions contain HPV DNA in an episomal state, but in most cases of cervical carcinomas the HPV DNA is found integrated into the host chromosomes, increasing expression of E6 and E7 (Munger and Howley, 2002; Hebner and Laimins, 2006) . The E6 protein promotes ubiquitination and proteasomal degradation of the tumor suppressor protein p53 (Huibregtse et al., 1991; Lechner et al., 1992; Band et al., 1993; Thomas et al., 1999) and PDZ domain-containing disc large protein (DLG) (Gardiol et al., 1999) . The E7 protein binds to and inactivates the function of the pRB and related tumor suppressor proteins p107 and p130 (Munger and Howley, 2002) . E7 also interacts with additional cellular proteins, such as TATA-binding protein, histone H1 kinase and cyclin E (Massimi et al., 1996; Hebner and Laimins, 2006) . In addition, E6/E7 expression promotes chromosomal instability, foreign DNA integration and other mutagenic events in the cell (Duensing et al., 2000; Hebner and Laimins, 2006) . MicroRNAs (miRNAs) are small noncoding RNAs that may regulate thousands of mRNA targets (for reviews, see Lewis et al., 2005; Calin and Croce, 2006) . MiRNAs are transcribed in the nucleus and after processing they associate with the RNA-induced silencing complex and act as negative regulators of gene expression by binding to complementary sequences in the 3 0 UTR of mRNA targets and either repressing translation or promoting mRNA degradation (Kim, 2005) . Recently, changes in the expression of miRNAs have been shown to be associated with a variety of human cancers (Calin and Croce, 2006) .
In this study, we demonstrate differential expression of several miRNAs in HPV-16-positive cervical cell lines and tissues, as well as in the HPV-18-positive cell line HeLa, compared to the normal cervical tissue and an HPV-negative cervical carcinoma cell line. We also demonstrate that microRNA-218 (miR-218) and the tumor suppressor gene SLIT2 are specifically downregulated in several HPV-16-positive cervical cell lines and tissues, and this effect is mediated by the E6 oncogene of high-risk HPV-16. Finally, our studies show that LAMB3 is a possible target of miR-218 at the transcriptional level.
Results
Differential expression of miRNAs in cervical cell lines compared to the normal cervix and the HPV-negative cell line C-33A MiRNA microarray analysis showed that approximately 220 known human miRNAs out of 328 represented on the array were expressed in the normal cervix (Supplementary Table 1 ). The miRNAs that were most highly expressed in the cervix were miR-145, -26a, -99a, let-7a, miR-143, let-7b, let-7c, miR-125b, miR-126 and miR-195 in that order. We investigated the miRNA expression profile in normal cervical tissue and cervical carcinoma cell lines SiHa and CaSki containing integrated HPV-16 DNA. We also used two clonal derivatives, 20861 and 201402, of the W12 cell line derived from a low-grade cervical intraepithelial neoplasia grade I (CIN I) lesion (Stanley et al., 1989) , which contain integrated HPV-16 DNA (Alazawi et al., 2002) . Significance analysis of microarray (SAM) analysis of the array data showed that 24 miRNAs, including miR-126, -143, -145 and miR-195 (four of the ten most highly expressed miRNAs in the normal cervix) were underexpressed in all the integrated HPV-16 cervical cell lines compared to the normal cervix (Table 1) . Only three miRNAs, miR-182, miR-183 and miR-210, were found to be overexpressed in the integrated HPV-16 cell lines (Table 1) . The array data for individual cell lines compared to the normal cervix is presented in Supplementary Table 2. In the 20863 cell line (a clonal derivative of the W12 cell line) containing episomal HPV-16 DNA, six miRNAs were underexpressed compared to the normal cervix (Supplementary Table 2 ). A direct comparison of the miRNA expression profiles of integrated versus episomal HPV-16 cell lines did not reveal any significant differences (data not shown). This, at least in part, may result from the use of only one cell line containing episomal HPV-16 DNA, as well as the use of a twofold cutoff value and a q-value of 0 in our statistical analysis.
MiRNA expression profile of the HPV-18 containing HeLa cell line showed that 14 miRNAs were underexpressed in HeLa cells compared to the normal cervix (Supplementary Table 3 ). Eight of these miRNAs (miR-1, miR-133b, miR-143, miR-145, miR-214, miR-368, miR-451 and ambi-miR-7029) were also found to be underexpressed in cell lines containing integrated HPV-16 DNA (Table 1) . Thirteen miRNAs were found to be overexpressed in the HeLa cell line compared to the normal cervix (Supplementary Table 3 ). Of these, two miRNAs (miR-182 and miR-183) were also overexpressed in the HPV-16-integrated cell lines (Table 1) .
Nine miRNAs in cell lines containing integrated HPV-16 DNA were found to be expressed at much higher levels compared to the HPV-negative cervical carcinoma cell line C-33A cells (Table 2) . Interestingly, miR-218 was the only miRNA that was underexpressed in the cell lines containing integrated HPV-16 DNA as compared to both the normal cervix and C-33A (Tables  1 and 2 ). This suggested that miR-218 may be specifically affected in the presence of HPV-16. The array data for individual cell lines compared to C-33A is presented in Supplementary Table 4 .
The HPV-18-positive HeLa cell line showed overexpression of six miRNAs compared to the HPVnegative cell line C-33A (Supplementary Table 5 ). Of these, three miRNAs (miR-31, miR-34a and miR-193b) were also overexpressed in integrated HPV-16 cell lines compared to C-33A (Table 2) . Finally, the array data for the HPV-negative cell line C-33A showed that four (miR-143, miR-145, miR-200c and miR-203) were underexpressed as compared to the normal cervix (Supplementary Table 6 ). In addition, quantitative realtime-PCR (qRT-PCR) and northern blot analyses showed that miR-193b, miR-205 and miR-497 were also downregulated in the C-33A cell line compared to the normal cervix (see below).
Validation of the miRNA microarray expression data by quantitative real-time RT-PCR and northern blot analyses The miRNA microarray results were validated by qRT-PCR and northern blot analyses of eight representative miRNAs representing those whose expression was either most affected, known to be affected in other types of cancers or one that appeared to be HPV-specific ( 
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shown that SLIT2 was underexpressed in the HPVpositive cell lines. The qRT-PCR results showed that SLIT2 expression paralleled that of miR-218, and both of these were underexpressed in the CIN III and CaCx tissues (Figure 2 ). MiRNAs 143, 145 and 497 that were underexpressed in the HPV-16-positive cell lines were also underexpressed in the HPV-positive tissues compared to the normal cervical tissue (Figure 2 ), although the relative levels of various miRNAs varied between the individual samples. In the case of miR-368, five out of eight cervical cancer and CIN III lesions showed downregulation as compared to the normal cervix (Figure 2) . Overall, the results obtained with the tissues provide further validation of the data obtained with the cervical cell lines.
HPV-16 E6 oncogene downregulates miR-218
To test whether E6 and/or E7 expression is directly correlated with reduced expression of miR-218, we utilized the osteosarcoma cell line U2OS either expressing the HPV-16 E6 or E7 gene, or the control neomycin resistance gene. The qRT-PCR results showed that both miR-218 and SLIT2 were underexpressed in the U2OS-E6 cell line compared to U2OS-E7 and the control U2OS-NEO cell line (Figure 3a) . In another approach, the 20861 cell line containing integrated HPV-16 was transfected with HPV-16 E6/E7 small interfering RNAs (siRNAs). Since E6 and E7 are derived from alternative splicing of the same RNA, a specific siRNA for E6 alone could not be used. The E6/E7 siRNAs reduced expression of these genes while increasing the expression of both miR-218 and the SLIT2 gene in 20861 cells (Figure 3b) . These results indicate that the HPV-16 E6 gene is involved in the downregulation of miR-218 and the SLIT2 gene in HPV-16-positive cell lines. Since a U2OS derivative expressing the E6 gene of a low-risk HPV is not available, we utilized normal oral keratinocytes (NOK) expressing the HPV-6 E6 gene to study whether the E6 gene of a low-risk HPV also affects miR-218 expression. The qRT-PCR analysis showed that NOK-16E6 cells had reduced expression of miR-218 compared to both NOK-NEO and NOK-6E6 (Figure 3c ). These results suggest that the E6 gene of the high-risk HPV-16, but not the low-risk HPV-6, reduces miR-218 expression.
Laminin-5 b3 is a transcriptional target of miR-218
To identify possible miR-218 targets, we compared computationally predicted targets in the miRBase Registry (Griffiths-Jones et al., 2006) with our gene expression data (manuscript in preparation), and then used the program rna22 (http://cbcsrv.watson.ibm.com/rna22. html). This analysis revealed six possible targets of miR-218: emopamil-binding protein, mitochondrial ribosomal protein S27, nucleoporin 93 kDa, ephrin-A1, laminin-5 b3 (LAMB3) and muscleblind-like 2. The expression of these genes was analysed by qRT-PCR in SiHa and 20861 cell lines transfected with an artificial miR-218 precursor molecule. After confirming the expression of mature miR-218 (Figure 4a ), we found that only the LAMB3 transcript was significantly underexpressed in miR-218-expressing cells (Figure 4b ; data not shown). Furthermore, western blot analysis showed that miR-218 expression also greatly reduced the levels of the LAMB3 protein in SiHa cells (Figure 4c ). We also found that LAMB3 was underexpressed in the 20861 cell line in the presence of the E6/E7 siRNAs compared to a control oligo (Figure 4d) . Furthermore, U2OS-16E6 cells showed an increase in the levels of LAMB3 mRNA as compared to the U2OS-NEO cells (Figure 4d ). Taken together, these results demonstrate that miR-218 reduces LAMB3 expression at the transcriptional level.
Discussion
The microarray data showed that 24 miRNAs were underexpressed and 3 overexpressed in integrated HPV-16 cell lines compared to the normal cervix (Table 1) . We also validated these data by northern blot and Supplementary Table 7 . The observed differences in the levels of differentially expressed miRNAs were generally much greater in qRT-PCR and northern blot studies as compared to the array data. Thus, the array data likely underestimate the fold changes in the levels of differentially expressed miRNAs. Our studies identified 10 underexpressed miRNAs in integrated HPV-16 cell lines that are not known to be altered in any cancers. These included seven known human miRNAs, miR-1, miR-126-AS, miR-133a, miR-376a, miR-451, miR-487b, miR-495, and three predicted miRNAs, ambi-miR-5021, ambi-miR-7029 and ambimiR-7070. MiR-143 and miR-145, which are underexpressed in colon and breast cancers (Calin and Croce, 2006) , were also underexpressed in all cervical cell lines including C-33A (Tables 1 and 2 ), suggesting that they may be important in cervical carcinogenesis independent of HPV infection. MiR-368, miR-497, which are underexpressed in integrated HPV-16 cell lines, and miR-193b, which is overexpressed in integrated HPV-16 cell lines, are known to be underexpressed in colon cancer cell lines (Bandres et al., 2006) , papillary thyroid carcinomas (Calin and Croce, 2006) and colon cancer (Cummins et al., 2006) , respectively. Interestingly, miR-218 was the only miRNA found to be underexpressed in integrated HPV-16 cell lines compared to both the normal cervix and C-33A cells (Tables 1 and 2 ; Figure 1 ). Northern blot and qRT-PCR analysis showed that miR-218 is also underexpressed in HeLa cells containing integrated HPV-18 DNA and the 20863 cell line containing episomal HPV-16 DNA (Figure 1;  Supplementary Figure 1) . These results suggest that HPV-16 downregulates miR-218 I Martinez et al miR-218 may be a specific cellular target of high-risk HPVs. MiR-218 is known to be underexpressed in several cancers and the DNA encoding miR-218 is also deleted in ovarian, breast and melanoma cancers (Calin and Croce, 2006; Zhang et al., 2006) . Of the miRNAs overexpressed in integrated HPV-16 cell lines, miR-210 is overexpressed in many epithelial cancers (Calin and Croce, 2006) , while miR-182 and miR-183 are overexpressed in colon cancer cell lines (Bandres et al., 2006) . We also found that six miRNAs have reduced expression in the episomal HPV-16 cell line 20863 compared to the normal cervix (Supplementary Table 2 (Figures 1 and 2) . Importantly, miR-218 was also underexpressed (>twofold difference) in all the CIN III and CaCx tissues (Figure 2 ). These results suggest that miR-218 underexpression is likely linked to the process of HPV-associated carcinogenesis in vivo. The parallel expression of miR-218 and the SLIT2 gene (which encodes miR-218) in all the tumor tissues (Figure 2 ) suggests that they may be coordinately regulated. Previous studies have shown that the SLIT2 tumor suppressor gene is frequently inactivated in lung and breast cancers (which have reduced miR-218 levels) (Dallol et al., 2002) . Whether regulation of SLIT2 plays a role in the pathogenesis of HPV-associated malignancies is currently unknown.
Our results showed that both miR-218 and SLIT2 were underexpressed in the U2OS-16E6 cell line (Figure 3a) . Similarly, miR-218 was also underexpressed in NOK-16E6 but not in the NOK-6E6 cell line (Figure 3c ). These results suggest that E6 of the highrisk HPV-16, but not the low-risk HPV-6, may contribute to the downregulation of miR-218. This possibility is also supported by our observations that expression of E6/E7 siRNAs in 20861 cells increases miR-218 and SLIT2 mRNA levels (Figure 3b) . Interestingly, SLIT2 is a possible target of miR-200c (overexpressed in the HPV-positive cell lines and tissues) (Supplementary Table 7) . One study has shown that the absence of the p53 gene increases miR-200c expression (Xi et al., 2006) . Thus, it is possible that E6-dependent degradation of the p53 protein results in miR-200c overexpression, which in turn reduces the levels of miR-218 and SLIT2 mRNA.
Our studies showed that introduction of miR-218 into SiHa and 20861 cell lines reduced the levels of LAMB3 mRNA as well as the protein (Figures 4a-c) . This strongly implies that miR-218 can downregulate LAMB3 expression independent of SLIT2. Furthermore, introduction of E6/E7 siRNA into the 20861 cell line also reduced LAMB3 expression (Figure 4d) . Also, E6 expression in U2OS cells increased LAMB3 expression (Figure 4d ) presumably by reducing miR-218 expression. Taken together, the above studies suggest that miR-218 may regulate LAMB3 expression at the transcriptional level. LAMB3 protein is part of the polymeric cell surface receptor laminin-5 that is expressed in the basal lamina of the epithelium and is overexpressed in cervical cancers (Skyldberg et al., 1999; Kohlberger et al., 2003) . LAMB3 increases cell migration and tumorigenicity in severe combined immunodeficient mice, and in collaboration with its ligand a6b4-integrin promotes tumorigenesis in human keratinocytes (Dajee et al., 2003; Calaluce et al., 2004) . A recent study suggests that secreted laminin-5 can be used by HPV as a transient receptor to aid the virus in the infection of basal cells that express a6b4-integrin (Culp et al., 2006) . Thus, downregulation of miR-218 by E6 and the consequent overexpression of LAMB3 may promote viral infection of the surrounding tissue and contribute to eventual tumorigenesis.
Materials and methods

Cell lines
Cervical cancer cell lines CaSki, SiHa (HPV-16-positive), HeLa (HPV-18-positive) and C-33A (HPV-negative) and their growth conditions have been described (Meissner, 1999) . Three clonal populations of the HPV-16 cervical cell line W12, 20863 (episomal HPV-16), 20861 and 201402 (integrated HPV-16) were obtained from the laboratories of Dr Margaret Stanley and Dr Paul Lambert (Medical Research Council, UK and University of Wisconsin, WA, USA, respectively). The cell lines U2OS-NEO, U2OS-E6 and U2OS-E7 (Duensing et al., 2000) were obtained from Dr Stefan Duensing (University of Pittsburgh, PA, USA). NOK cell lines immortalized by hTERT expression and expressing the E6 gene of HPV-6 or HPV-16 (Piboonniyom et al., 2003) were obtained from Dr Stefan Duensing and Dr Karl Munger (Harvard University) .
Cervical tissues characteristics
Human cervical tissue samples were collected under an institutional review board-approved protocol from patients with cervical preinvasive neoplasia undergoing LEEP excision or radical hysterectomy for invasive cervical cancer. Informed consent was obtained from all subjects. Parallel specimens of the same site were stained (hematoxylin and eosin) to confirm the diagnosis. HPV-16 positivity was confirmed by reverse transcriptase-PCR (RT)-PCR. Total RNA from normal human cervix was obtained from a pool of two different donors (Stratagene LaJolla, CA, USA). Prior to further RNA purification, these preparations contained limited levels of cellular DNA and were used to confirm the absence of HPV DNA. PCR amplification showed positive results for glyceraldehyde-3-phosphate dehydrogenase gene (G3PDH) and negative results for several HPV types using the degenerate MY09/MY11 primer pair (Manos et al., 1994) . Furthermore, the preparations also did not give any PCR signals for the HPV-16 E7 and E2 genes. CaSki cells were used as a positive control and gave positive signals for the G3PDH gene as well as for the HPV L1 gene and HPV-16 E7 and E2 genes (data not shown).
MiRNA microarray analysis
Total RNA was extracted using the Ultraspec RNA isolation system (Biotecx, Houston, TX, USA) according to the manufacturer's instructions. Total RNA from cell lines and normal cervix was used to isolate small RNAs (o200 nt) which includes miRNAs using the RNeasy Mini Kit and the MinElute Cleanup Kit (Qiagen, Valencia, CA, USA). MirVana miRNA Bioarray (Ambion) was used to analyse miRNA expression in cervical cell lines. The Bioarray consist of 662 probes (B22 ntlong antisense oligonucleotides) that include known human miRNAs (328), theoretical human microarrays known as ambimiRs (152) as well as unique miRNAs from mouse (114) and rat (46). Each array contains probes for all miRNAs in quadruplicate, and the signals obtained for each miRNA is represented as an average of these four values. The enriched small RNA fractions obtained from 25 mg of total RNA were fluorescently labeled and hybridized to the Bioarrays according to the manufacturer's instructions (Ambion). Each experiment was done twice. The Bioarrays were scanned using GenePix 4000B Scanner and the median fluorescent intensity was obtained after subtracting the background using the GenePix Pro 6.0 software. To identify differential miRNA expression between samples, the median fluorescent intensities were log 2 transformed and normalized using the median within the array and the global mean adjustment among arrays using the GEDA program (http://bioinformatics.upmc.edu/Help/ GEDADescription.html). After transformation and normalization, we used the SAM program version 1.21 (www-stat. stanford.edu/Btibs/SAM/) to obtain the differential expression profiles.
MiRNA northern blot analysis
Enriched miRNA fractions obtained from 25 mg of total RNA were separated on 15% urea-containing polyacrylamide gels, transferred onto GeneScreen Plus membranes and hybridized to 32 P-labeled oligonucleotide probes complementary to various cellular miRNAs. We hybridized a probe complementary to the housekeeping splicing-related small U6 RNA for loading control. Hybridization was carried out overnight at 50 1C and the membranes were subjected to autoradiography at À80 1C.
MiRNA and mRNA real-time quantitative RT-PCR analysis DNase I-treated total RNA (10 ng) was subjected to qRT-PCR analysis using the TaqMan miRNA Reverse Transcription Kit and miRNA Assays (Applied Biosystems, Foster City, CA, USA), and the Real-Time thermocycler iQ5 (Bio-Rad, Hercules, CA, USA). The small nucleolar RNU43 was used as the housekeeping small RNA reference gene. For qRT-PCR analysis of SLIT2 and LAMB3 mRNAs, the following primers were used: (SLIT2, forward 5 0 -CTGTGAATGCAGCAGTG GAT-3 0 and reverse 5 0 -TTGTTTGGCAAGCAGCATAG-3 0 (116 bp product); LAMB3, forward 5 0 -GGGAGACCATGGA GATGATG-3' and reverse 5 0 -ACACGCTTCTCCAGTCCT GT-3 0 (112 bp product). Also, 500 ng of total RNA from the cervical samples was amplified using the one-step QuantiTect SYBR Green RT-PCR Master Mix (Qiagen). The primer sequences for the control housekeeping G3PDH have been described previously (Martinez et al., 2007) . All reactions were done in triplicate and relative expression of RNAs was calculated using the two DC T method (Livak and Schmittgen, 2001 ).
HPV-16 E6 and E7 siRNA and transfection assays Double-stranded siRNAs against HPV-16 E6 (siRNA 209, 5 0 -UCCAUAUGCUGUAUGUGAUTT-3 0 ; complementary to HPV-16 positions 277 to 298) and E7 (E7 siRNA, 5 0 -CCAUCUAUUUCAUCCUCCUTT-3 0 , complementary to HPV-16 positions 662-682) (Jiang and Milner, 2002; Tang et al., 2006) were obtained from Dharmacon, Lafayette, CO, USA. BLOCK-iT Fluorescent double-stranded oligo (with no human homologous sequence) was used as a negative control as well as to measure the transfection efficiency (Invitrogen, Carlsbad, CA, USA). MiR-218 was expressed in cell lines by transfecting with a Pre-miR miR-218 precursor molecule (Ambion). Cell lines were seeded (1.5 Â 10 5 ) into six-well plates, and after 24 h transfected (125 nM per well of HPV siRNAs or 100 nM of Pre-miR miR-218 precursor molecule) using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer's instructions. Cells were harvested after 72 h, and RNA and protein extractions were performed.
Western blot analysis
A total of 20 mg of total cellular proteins were separated on 7.5% sodium dodecyl sulfate-polyacrylamide gels, transferred to Immobilon-P PVDF membranes (Millipore Billerica, MA, USA) and incubated with primary murine monoclonal antibody (Calaluce et al., 2004) against the b3 chain of laminin-5 (Kalinin B1; BD Biosciences, San Jose, CA, USA). The membranes were subsequently incubated with a 1:5000 dilution of the secondary anti-mouse horseradish peroxidase antibody (Amersham Biosciences, Piscataway, NJ, USA). Specific proteins were detected using chemiluminescence with ECL plus western blotting detection reagents (Amersham Biosciences). Murine monoclonal antibody against G3PDH (Chemicon, Temecula, CA, USA) was used to demonstrate equal loading.
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